Platinumā€induced hearing loss after treatment for childhood cancer

Source:
Cochrane Database of Systematic Reviews
Publisher:
Cochrane Database of Systematic Reviews
Publication date:
24 November 2016

Abstract

This review shows children treated with platinum analogues are at risk of developing hearing loss, but the exact prevalence and risk factors remain unclear. There were no data available for tinnitus. Children should be screened for ototoxicity for early diagnosis and management.